Current developments in neurology, part II: Advances in the pharmacotherapy of Alzheimer disease, Parkinson's disease, and stroke

Barry E. Gidal, M. Lynn Crismon, Mary L. Wagner, Susan C. Fagan, Michael D. Privitera, Christina Dalmady-Israel, Nina M. Graves

Research output: Contribution to journalReview articlepeer-review

7 Scopus citations

Abstract

Disorders of the central nervous system provide innumerable challenges to the clinician. Often the underlying pathophysiology is not completely understood, thus preventing the design of treatment strategies aimed at correcting the underlying process. In this decade of the brain, basic science research combined with difficult but necessary clinical trials may answer some of these seemingly overwhelming questions for these devastating illnesses.

Original languageEnglish (US)
Pages (from-to)1446-1451
Number of pages6
JournalAnnals of Pharmacotherapy
Volume30
Issue number12
DOIs
StatePublished - 1996

ASJC Scopus subject areas

  • Pharmacology (medical)

Fingerprint

Dive into the research topics of 'Current developments in neurology, part II: Advances in the pharmacotherapy of Alzheimer disease, Parkinson's disease, and stroke'. Together they form a unique fingerprint.

Cite this